Prospera Biotech 

Innovative neurodermatological solutions to improve quality of life of cancer patients treated with chemotherapy

OWNER

Antonio Ferrer (See Profile)


Sector

Biotech

Stage

Sales, licensing phases

Country

Spain


Exclusive worldwide license for using the ingredient calmapsin to treat CIPN

A topical formulation that alleviates the disabling chemotherapy-induced peripheral neuropathy (CIPN)

A patented neurodermatological formulation to treat hyperhidrosis

A pipeline of neurodermatological formulations to treat sensitive and reactive skin

Status

Pending

IP Type

Patent

Time

–

Countries

Australia
Austria
Belgium
Canada
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
Russia
South Korea
Spain
Switzerland
USA

Coverage

-WO2018206742 – TRPV1 MODULATOR COMPOUNDS. This is the patent protecting Calmapsin (AntalGenics) for which Prospera Biotech has a worldwide exclusive license for the use in topical formulations to alleviate CIPN symptoms in cancer patients.

Know more of this patent

View more

Status

Pending

IP Type

Patent

Time

–

Countries

Australia
Austria
Belgium
China
Denmark
Finland
France
Germany
Israel
Italy
Japan
Netherlands
South Korea
Spain
Switzerland
USA
United Kingdom

Coverage

EU patent application (EP22382149.7, 2022) protecting a neurodermatology formulation to reduce hyperhidrosis and its cutaneous impact.

Know more of this patent

View more

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: Jan 20th 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar